These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


446 related items for PubMed ID: 19299325

  • 1. Neuroleptic malignant syndrome secondary to quetiapine.
    Gortney JS, Fagan A, Kissack JC.
    Ann Pharmacother; 2009 Apr; 43(4):785-91. PubMed ID: 19299325
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
    Khaldi S, Kornreich C, Choubani Z, Gourevitch R.
    Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
    [Abstract] [Full Text] [Related]

  • 5. Suspected neuroleptic malignant syndrome during quetiapine-clozapine cross-titration.
    Stoner SC, Berry A.
    J Pharm Pract; 2010 Feb; 23(1):69-73. PubMed ID: 21507795
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Neuroleptic malignant syndrome associated with the use of prochlorperazine in a patient with a recent history of antipsychotic-induced neuroleptic malignant syndrome.
    Musselman ME, Browning LA, Parker D, Saely S.
    Ann Pharmacother; 2011 Nov; 45(11):e61. PubMed ID: 21972252
    [Abstract] [Full Text] [Related]

  • 11. Atypical neuroleptic malignant syndrome: diagnostic controversies and considerations.
    Picard LS, Lindsay S, Strawn JR, Kaneria RM, Patel NC, Keck PE.
    Pharmacotherapy; 2008 Apr; 28(4):530-5. PubMed ID: 18363536
    [Abstract] [Full Text] [Related]

  • 12. Neuroleptic malignant syndrome in traumatic brain injury patients treated with haloperidol.
    Bellamy CJ, Kane-Gill SL, Falcione BA, Seybert AL.
    J Trauma; 2009 Mar; 66(3):954-8. PubMed ID: 19276778
    [Abstract] [Full Text] [Related]

  • 13. Possible neuroleptic malignant syndrome related to concomitant treatment with paroxetine and alprazolam.
    Tanii H, Ichihashi K, Inoue K, Fujita K, Okazaki Y.
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug 30; 30(6):1176-8. PubMed ID: 16720068
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Seizures associated with quetiapine treatment.
    Dogu O, Sevim S, Kaleagasi HS.
    Ann Pharmacother; 2003 Sep 30; 37(9):1224-7. PubMed ID: 12921503
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Diagnosis and treatment of neuroleptic malignant syndrome.
    Guerrero RM, Shifrar KA.
    Clin Pharm; 1988 Sep 30; 7(9):697-701. PubMed ID: 3240662
    [Abstract] [Full Text] [Related]

  • 19. Possible contribution of XYY syndrome to neuroleptic malignant syndrome in a child receiving quetiapine.
    Randolph TC.
    Am J Health Syst Pharm; 2010 Mar 15; 67(6):459-61. PubMed ID: 20208052
    [Abstract] [Full Text] [Related]

  • 20. Neuroleptic malignant syndrome or a statin drug reaction? A case report.
    Cooper JM, Jones AL.
    Clin Neuropharmacol; 2009 Mar 15; 32(6):348-9. PubMed ID: 19952877
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 23.